Segment Disclosures - Summary Information for the Reportable Segments (Details) - USD ($) $ in Thousands	1 Months Ended		3 Months Ended				6 Months Ended
	Mar. 31, 2023	Jan. 31, 2023	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			$ 545,430		$ 517,932		$ 1,071,108	$ 1,016,304
Government grant income			47		209		184	6,762
Less: Interest income			(5,279)		(5,493)		(11,442)	(10,987)
Healthpeak’s share of unconsolidated joint venture total revenues			22,943		20,243		46,198	40,451
Healthpeak’s share of unconsolidated joint venture government grant income							229	648
Noncontrolling interests’ share of consolidated joint venture total revenues			(8,816)		(9,005)		(17,922)	(17,882)
Operating expenses			(221,837)		(215,044)		(444,925)	(422,291)
Healthpeak’s share of unconsolidated joint venture operating expenses			(15,754)		(14,934)		(32,249)	(29,771)
Noncontrolling interests’ share of consolidated joint venture operating expenses			2,444		2,745		5,079	5,366
Adjustments to NOI			(19,688)		(24,539)		(24,310)	(42,206)
Adjusted NOI			299,490		272,114		591,950	546,394
Plus: Adjustments to NOI			19,688		24,539		24,310	42,206
Interest income			5,279		5,493		11,442	10,987
Interest expense			(49,074)		(41,867)		(97,037)	(79,453)
Depreciation and amortization			(197,573)		(180,489)		(376,798)	(358,222)
General and administrative			(25,936)		(24,781)		(50,483)	(48,612)
Transaction costs			(637)		(612)		(3,062)	(908)
Impairments and loan loss reserves, net			(2,607)		(139)		(394)	(271)
Gain (loss) on sales of real estate, net			4,885		10,340		86,463	14,196
Other income (expense), net			1,955		2,861		2,727	21,177
Less: Government grant income			(47)		(209)		(184)	(6,762)
Less: Healthpeak’s share of unconsolidated joint venture NOI			(7,189)		(5,309)		(14,178)	(11,328)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			6,372		6,260		12,843	12,516
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			54,606		68,201		187,599	141,920
Income tax benefit (expense)			(1,136)		718		(1,438)	(59)
Equity income (loss) from unconsolidated joint ventures			2,729		382		4,545	2,466
Income (loss) from continuing operations			56,199		69,301		190,706	144,327
Income (loss) from discontinued operations			0		2,992		0	3,309
Net income (loss)			56,199		72,293		190,706	147,636
Corporate Non-segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			0		0		0	0
Government grant income			0		0		0	0
Less: Interest income			0		0		0	0
Healthpeak’s share of unconsolidated joint venture total revenues			0		0		0	0
Healthpeak’s share of unconsolidated joint venture government grant income							0	0
Noncontrolling interests’ share of consolidated joint venture total revenues			0		0		0	0
Operating expenses			0		0		0	0
Healthpeak’s share of unconsolidated joint venture operating expenses			0		0		0	0
Noncontrolling interests’ share of consolidated joint venture operating expenses			0		0		0	0
Adjustments to NOI			0		0		0	0
Adjusted NOI			0		0		0	0
Plus: Adjustments to NOI			0		0		0	0
Interest income			0		0		0	0
Interest expense			(45,327)		(38,061)		(89,553)	(72,746)
Depreciation and amortization			0		0		0	0
General and administrative			(25,936)		(24,781)		(50,483)	(48,612)
Transaction costs			(343)		(443)		(2,259)	(443)
Impairments and loan loss reserves, net			0		0		0	0
Gain (loss) on sales of real estate, net			0		0		0	0
Other income (expense), net			1,067		920		2,298	1,828
Less: Government grant income			0		0		0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI			0		0		0	0
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			0		0		0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			(70,539)		(62,365)		(139,997)	(119,973)
Income tax benefit (expense)			(1,136)		718		(1,438)	(59)
Equity income (loss) from unconsolidated joint ventures			0		0		0	0
Income (loss) from continuing operations			(71,675)		(61,647)		(141,435)	(120,032)
Income (loss) from discontinued operations			0		2,992		0	3,309
Net income (loss)			(71,675)		(58,655)		(141,435)	(116,723)
Lab
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net		$ 60,000				$ 4,000
Lab | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			223,306		207,771		428,770	401,826
Government grant income			0		0		0	0
Less: Interest income			0		0		0	0
Healthpeak’s share of unconsolidated joint venture total revenues			1,928		1,267		4,093	2,698
Healthpeak’s share of unconsolidated joint venture government grant income							0	0
Noncontrolling interests’ share of consolidated joint venture total revenues			(151)		(62)		(294)	(119)
Operating expenses			(54,832)		(49,446)		(112,397)	(97,635)
Healthpeak’s share of unconsolidated joint venture operating expenses			(848)		(483)		(2,030)	(966)
Noncontrolling interests’ share of consolidated joint venture operating expenses			35		19		75	38
Adjustments to NOI			(14,943)		(21,644)		(15,776)	(35,756)
Adjusted NOI			154,495		137,422		302,441	270,086
Plus: Adjustments to NOI			14,943		21,644		15,776	35,756
Interest income			0		0		0	0
Interest expense			0		0		0	0
Depreciation and amortization			(93,235)		(79,673)		(168,817)	(157,811)
General and administrative			0		0		0	0
Transaction costs			0		(35)		(158)	(327)
Impairments and loan loss reserves, net			0		0		0	0
Gain (loss) on sales of real estate, net			0		0		60,498	3,856
Other income (expense), net			(2)		29		2	20
Less: Government grant income			0		0		0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI			(1,080)		(784)		(2,063)	(1,732)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			116		43		219	81
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			75,237		78,646		207,898	149,929
Income tax benefit (expense)			0		0		0	0
Equity income (loss) from unconsolidated joint ventures			1,314		148		1,911	1,114
Income (loss) from continuing operations			76,551		78,794		209,809	151,043
Income (loss) from discontinued operations			0		0		0	0
Net income (loss)			76,551		78,794		209,809	151,043
Outpatient Medical
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Gain (loss) on sales of real estate, net	$ 21,000			$ 1,000	10,000
Outpatient Medical | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			186,661		179,308		373,628	356,571
Government grant income			0		0		0	0
Less: Interest income			0		0		0	0
Healthpeak’s share of unconsolidated joint venture total revenues			754		761		1,498	1,493
Healthpeak’s share of unconsolidated joint venture government grant income							0	0
Noncontrolling interests’ share of consolidated joint venture total revenues			(8,665)		(8,943)		(17,628)	(17,763)
Operating expenses			(65,350)		(63,321)		(129,749)	(124,491)
Healthpeak’s share of unconsolidated joint venture operating expenses			(288)		(301)		(595)	(600)
Noncontrolling interests’ share of consolidated joint venture operating expenses			2,409		2,726		5,004	5,328
Adjustments to NOI			(4,008)		(2,949)		(7,825)	(6,495)
Adjusted NOI			111,513		107,281		224,333	214,043
Plus: Adjustments to NOI			4,008		2,949		7,825	6,495
Interest income			0		0		0	0
Interest expense			(1,924)		(1,930)		(3,845)	(2,966)
Depreciation and amortization			(71,722)		(68,873)		(142,881)	(136,646)
General and administrative			0		0		0	0
Transaction costs			(16)		(70)		(148)	(74)
Impairments and loan loss reserves, net			0		0		0	0
Gain (loss) on sales of real estate, net			0		10,340		21,312	10,340
Other income (expense), net			235		1,264		439	12,201
Less: Government grant income			0		0		0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI			(466)		(460)		(903)	(893)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			6,256		6,217		12,624	12,435
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			47,884		56,718		118,756	114,935
Income tax benefit (expense)			0		0		0	0
Equity income (loss) from unconsolidated joint ventures			184		211		374	411
Income (loss) from continuing operations			48,068		56,929		119,130	115,346
Income (loss) from discontinued operations			0		0		0	0
Net income (loss)			48,068		56,929		119,130	115,346
CCRC | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			130,184		125,360		257,268	246,920
Government grant income			47		209		184	6,762
Less: Interest income			0		0		0	0
Healthpeak’s share of unconsolidated joint venture total revenues			0		0		0	0
Healthpeak’s share of unconsolidated joint venture government grant income							0	333
Noncontrolling interests’ share of consolidated joint venture total revenues			0		0		0	0
Operating expenses			(101,655)		(102,277)		(202,779)	(200,165)
Healthpeak’s share of unconsolidated joint venture operating expenses			0		0		0	0
Noncontrolling interests’ share of consolidated joint venture operating expenses			0		0		0	0
Adjustments to NOI			(728)		0		(678)	0
Adjusted NOI			27,848		23,292		53,995	53,850
Plus: Adjustments to NOI			728		0		678	0
Interest income			0		0		0	0
Interest expense			(1,823)		(1,876)		(3,639)	(3,741)
Depreciation and amortization			(32,616)		(31,943)		(65,100)	(63,765)
General and administrative			0		0		0	0
Transaction costs			(278)		(64)		(497)	(64)
Impairments and loan loss reserves, net			0		0		0	0
Gain (loss) on sales of real estate, net			0		0		0	0
Other income (expense), net			674		630		7	7,141
Less: Government grant income			(47)		(209)		(184)	(6,762)
Less: Healthpeak’s share of unconsolidated joint venture NOI			0		0		0	(333)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			0		0		0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			(5,514)		(10,170)		(14,740)	(13,674)
Income tax benefit (expense)			0		0		0	0
Equity income (loss) from unconsolidated joint ventures			0		0		0	539
Income (loss) from continuing operations			(5,514)		(10,170)		(14,740)	(13,135)
Income (loss) from discontinued operations			0		0		0	0
Net income (loss)			(5,514)		(10,170)		(14,740)	(13,135)
Other Non-reportable | Operating Segment
Segment Reporting Information, Revenue for Reportable Segment [Abstract]
Total revenues			5,279		5,493		11,442	10,987
Government grant income			0		0		0	0
Less: Interest income			(5,279)		(5,493)		(11,442)	(10,987)
Healthpeak’s share of unconsolidated joint venture total revenues			20,261		18,215		40,607	36,260
Healthpeak’s share of unconsolidated joint venture government grant income							229	315
Noncontrolling interests’ share of consolidated joint venture total revenues			0		0		0	0
Operating expenses			0		0		0	0
Healthpeak’s share of unconsolidated joint venture operating expenses			(14,618)		(14,150)		(29,624)	(28,205)
Noncontrolling interests’ share of consolidated joint venture operating expenses			0		0		0	0
Adjustments to NOI			(9)		54		(31)	45
Adjusted NOI			5,634		4,119		11,181	8,415
Plus: Adjustments to NOI			9		(54)		31	(45)
Interest income			5,279		5,493		11,442	10,987
Interest expense			0		0		0	0
Depreciation and amortization			0		0		0	0
General and administrative			0		0		0	0
Transaction costs			0		0		0	0
Impairments and loan loss reserves, net			(2,607)		(139)		(394)	(271)
Gain (loss) on sales of real estate, net			4,885		0		4,653	0
Other income (expense), net			(19)		18		(19)	(13)
Less: Government grant income			0		0		0	0
Less: Healthpeak’s share of unconsolidated joint venture NOI			(5,643)		(4,065)		(11,212)	(8,370)
Plus: Noncontrolling interests’ share of consolidated joint venture NOI			0		0		0	0
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures			7,538		5,372		15,682	10,703
Income tax benefit (expense)			0		0		0	0
Equity income (loss) from unconsolidated joint ventures			1,231		23		2,260	402
Income (loss) from continuing operations			8,769		5,395		17,942	11,105
Income (loss) from discontinued operations			0		0		0	0
Net income (loss)			$ 8,769		$ 5,395		$ 17,942	$ 11,105